| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
4008200310 |
| Email: |
marketing@tsbiochem.com |
| Products Intro: |
Product Name:Degranol;Degranol
CAS:551-74-6
Purity:98% Package:5 mg
|
|
| | Mannomustine Basic information |
| Product Name: | Mannomustine | | Synonyms: | MANNOMUSTINEHYDROCHLORIDE;MANNOUMUSINEDIHYDROCHLORIDE;Mannomustine dihydrochloride;1,6-Bis-(.beta.-chloraethylamino)-1,6-desoxy-D-mannit-dichlorhydrat;1,6-Bis[(chloroethyl)amino]-1,6-desoxy-D-mannitol dihydrochloride;1,6-Bis[(chloroethyl)amino]-1,6-dideoxy-D-mannite dihydrochloride;1,6-Dideoxy-1,6-di[(2-chloroethyl)amino]-D-mannitol dihydrochloride;Degranol | | CAS: | 551-74-6 | | MF: | C10H22Cl2N2O4.2ClH | | MW: | 378.122 | | EINECS: | | | Product Categories: | | | Mol File: | 551-74-6.mol |  |
| | Mannomustine Chemical Properties |
| Melting point | 240-242 °C | | alpha | D20 +18.46° (c = 1.81 in H2O) | | CAS DataBase Reference | 551-74-6 | | IARC | 3 (Vol. 9, Sup 7) 1987 | | EPA Substance Registry System | Degranol (551-74-6) |
| Toxicity | LD50 i.v. in rats: 56 mg/kg (Scherf) |
| | Mannomustine Usage And Synthesis |
| Definition | ChEBI: Mannomustine dihydrochloride is an organic molecular entity. | | Safety Profile | Poison by intravenous,
subcutaneous, and parented routes.
Experimental reproductive effects.
Questionable carcinogen with experimental
carcinogenic and neoplastigenic data. Human mutation data reported. A drug used
for the treatment of malignant neoplasms.
When heated to decomposition it emits very
toxic fumes of HCl and NOx. See also
MANNOMUSTINE. |
| | Mannomustine Preparation Products And Raw materials |
|